Gene · 5430
Papers4,359
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,359
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elongation roadblocks mediated by dCas9 across human genes modulate transcription and nascent RNA processing. | Nat Struct Mol Biol | 2023 | 37783853 | PubTator, text mining | PubMed |
| 8-Oxoguanine DNA glycosylase 1 selectively modulates ROS-responsive NF-κB targets through recruitment of MSK1 and phosphorylation of RelA/p65 at Ser276. | J Biol Chem | 2023 | 37778730 | PubTator, text mining | PubMed |
| Cla4 phosphorylates histone methyltransferase Set1 to prevent its degradation by the APC/CCdh1 complex. | Sci Adv | 2023 | 37774018 | PubTator, text mining | PubMed |
| The management of symptomatic hyperostotic bilateral spheno-orbital meningiomas: patient series. | J Neurosurg Case Lessons | 2023 | 37773763 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers. | Genes (Basel) | 2023 | 37761830 | PubTator, text mining | PubMed |
| A Truncated Receptor TrkB Isoform (TrkB.T1) in Mechanisms of Genetically Determined Depressive-like Behavior of Mice. | Biomedicines | 2023 | 37761014 | PubTator, text mining | PubMed |
| Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications. | Cancers (Basel) | 2023 | 37760490 | PubTator, text mining | PubMed |
| Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases. | Biology (Basel) | 2023 | 37759656 | PubTator, text mining | PubMed |
| New Species of Bioluminescent Mycena Sect. Calodontes (Agaricales, Mycenaceae) from Mexico. | J Fungi (Basel) | 2023 | 37755010 | PubTator, text mining | PubMed |
| The unique interplay of mitochondrial oxidative phosphorylation (OXPHOS) and immunity and its potential implication for the sex- and age-related morbidity of severe COVID-19 patients. | MedComm (2020) | 2023 | 37750090 | PubTator, text mining | PubMed |
| Driving forces behind phase separation of the carboxy-terminal domain of RNA polymerase II. | Nat Commun | 2023 | 37749095 | PubTator, text mining | PubMed |
| RNA Polymerase II evolution and adaptations: Insights from Plasmodium and other parasitic protists. | Infect Genet Evol | 2023 | 37748526 | PubTator, text mining | PubMed |
| mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies. | Sci Rep | 2023 | 37743371 | PubTator, text mining | PubMed |
| Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing. | J Am Chem Soc | 2023 | 37733759 | PubTator, text mining | PubMed |
| MDA5 RNA-sensing pathway activation by Mycobacterium tuberculosis promotes innate immune subversion and pathogen survival. | JCI Insight | 2023 | 37725440 | PubTator, text mining | PubMed |
| OTUD5 limits replication fork instability by organizing chromatin remodelers. | Nucleic Acids Res | 2023 | 37713620 | PubTator, text mining | PubMed |
| Radiotherapy and radiosurgery for meningiomas. | Neurooncol Adv | 2023 | 37711972 | PubTator, text mining | PubMed |
| Interpretable predictive models of genome-wide aryl hydrocarbon receptor-DNA binding reveal tissue-specific binding determinants. | Toxicol Sci | 2023 | 37707797 | PubTator, text mining | PubMed |
| Liquid‒liquid phase separation: roles and implications in future cancer treatment. | Int J Biol Sci | 2023 | 37705755 | PubTator, text mining | PubMed |
| Influence of host genetic polymorphisms involved in immune response and their role in the development of Chikungunya disease: a review. | Braz J Med Biol Res | 2023 | 37703107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5430/papers?page=17